{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicg6iyo7ko2snqorhpzuhfdqzj672p5wg5a425iooyyousq764fra",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mfcphaizocn2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiejt5wvxaivfci4csbetvmo5hnuc2vl7dkevlxsz6tc5lrekwewbe"
    },
    "mimeType": "image/jpeg",
    "size": 365492
  },
  "path": "/news/2026-02-pathway-common-brain-tumor.html",
  "publishedAt": "2026-02-20T12:49:56.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Oncology & Cancer"
  ],
  "textContent": "Northwestern Medicine scientists have discovered a potent immunotherapy approach for treating meningiomas, the most common type of primary brain tumor, according to a study published in Nature Communications.",
  "title": "How targeting the STING pathway could change care for a common brain tumor"
}